Загрузка...
Model‐based Meta‐Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
Recently, the US Food and Drug Administration (FDA) approved the first two drugs (pirfenidone and nintedanib) indicated for the treatment of idiopathic pulmonary fibrosis (IPF). The purpose of this analysis was to leverage publicly available data to quantify comparative efficacy of compounds that ar...
Сохранить в:
| Опубликовано в: : | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5658284/ https://ncbi.nlm.nih.gov/pubmed/28699195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12227 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|